UBS Group AG reduced its position in BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Free Report) by 2.7% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,153,445 shares of the company’s stock after selling 31,428 shares during the period. UBS Group AG’s holdings in BlackRock Science and Technology Term Trust were worth $26,079,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. US Bancorp DE boosted its position in BlackRock Science and Technology Term Trust by 165.3% in the 3rd quarter. US Bancorp DE now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 1,124 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in BlackRock Science and Technology Term Trust in the 1st quarter valued at about $40,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in BlackRock Science and Technology Term Trust in the 4th quarter valued at about $141,000. Advisory Services Network LLC purchased a new position in BlackRock Science and Technology Term Trust in the 3rd quarter valued at about $147,000. Finally, Northwestern Mutual Wealth Management Co. boosted its position in BlackRock Science and Technology Term Trust by 13.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 6,638 shares of the company’s stock valued at $138,000 after buying an additional 767 shares during the last quarter.
BlackRock Science and Technology Term Trust Price Performance
NASDAQ:BSTZ opened at $27.97 on Monday. The firm has a 50-day moving average of $23.36 and a two-hundred day moving average of $22.80. BlackRock Science and Technology Term Trust has a 1-year low of $18.15 and a 1-year high of $28.51.
BlackRock Science and Technology Term Trust Dividend Announcement
About BlackRock Science and Technology Term Trust
BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.
The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.
Recommended Stories
- Five stocks we like better than BlackRock Science and Technology Term Trust
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Want to see what other hedge funds are holding BSTZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Free Report).
Receive News & Ratings for BlackRock Science and Technology Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Science and Technology Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
